Biotech · Private company · Waltham, MA, US

Motive Therapeutics, Inc.

Track this companyFree. Adds Motive Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards1

State-Mediated mRNA Translation (SMRT) Systems to Control the Expression of Therapeutic mRNAsFiscal year 2026 · $356.4KNIH RePORTER 1R43GM160988-01A1 · fetched Nov 12, 2026